| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81e243c24e2d8b153bc48dbb944b4785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65d4a0ae6173bc40a4c88035455562c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef54e0cd216e033f2f0bcca849bdd5de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9106d7c5a4c2e62de42329b824a53904 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2011-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021e5e230e523a30eceb0c30620c8ce0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798d2f247673b409ea4d8e3201e537e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667757ed687cf034fa79e923ef0226d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8ce78536af1f8a642161081a7301980 |
| publicationDate |
2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012028898-A1 |
| titleOfInvention |
Methods for treatment of headaches by administration of oxytocin |
| abstract |
The present invention relates to methods for the treatment of headache and headache disorders. The methods comprise administration of an oxytocin peptide for the treatment of primary and secondary headaches or trigeminal neuralgia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551949-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9238053-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011021426-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020061584-A1 |
| priorityDate |
2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |